FibroBiologics Inc. (NASDAQ: FBLG) terminated a sublease agreement for office space in Webster, Texas, effective April 2, 2026, according to a company statement.

The company entered into a sublease buyout agreement on April 3, 2026, with United Fire & Casualty Co. to end the sublease for premises located on the third floor of 455 E. Medical Center Blvd. The original sublease, which began October 5, 2022, was scheduled to expire November 30, 2027.

FibroBiologics paid $45,108.25 to resolve remaining rent obligations and expects to save approximately $0.8 million in future rent payments by terminating the lease 18 months early.

The company stated the termination follows the 2025 opening of its laboratory facility, which spans over 10,000 square feet of lab and office space. The move eliminates what the company described as redundant office costs.